130 related articles for article (PubMed ID: 37909307)
1. Subclinical, early hair regrowth in alopecia areata patients under treatment with baricitinib detected by line-field confocal optical coherence tomography evaluation.
Verzì AE; Lacarrubba F; Dall'Oglio F; Rini S; Tosti A; Micali G
J Eur Acad Dermatol Venereol; 2024 Jun; 38(6):e459-e461. PubMed ID: 37909307
[No Abstract] [Full Text] [Related]
2. Oral Baricitinib Restores Hair Loss in Alopecia Areata.
Slomski A
JAMA; 2022 Jun; 327(24):2386. PubMed ID: 35762995
[No Abstract] [Full Text] [Related]
3. Effect of baricitinib in patients with alopecia areata: Usefulness of trichoscopic evaluation.
Diluvio L; Matteini E; Lambiase S; Cioni A; Gaeta Shumak R; Dattola A; Bianchi L; Campione E
J Eur Acad Dermatol Venereol; 2024 Jun; 38(6):e478-e480. PubMed ID: 38084867
[No Abstract] [Full Text] [Related]
4. Baricitinib in Alopecia Areata.
Messenger A; Harries M
N Engl J Med; 2022 May; 386(18):1751-1752. PubMed ID: 35507486
[No Abstract] [Full Text] [Related]
5. Two Phase 3 Trials of Baricitinib for Alopecia Areata.
King B; Ohyama M; Kwon O; Zlotogorski A; Ko J; Mesinkovska NA; Hordinsky M; Dutronc Y; Wu WS; McCollam J; Chiasserini C; Yu G; Stanley S; Holzwarth K; DeLozier AM; Sinclair R;
N Engl J Med; 2022 May; 386(18):1687-1699. PubMed ID: 35334197
[TBL] [Abstract][Full Text] [Related]
6. Baricitinib for the treatment of alopecia areata in adults: Real-world analysis of 36 patients.
Moreno-Vílchez C; Bonfill-Ortí M; Bauer-Alonso A; Notario J; Figueras-Nart I
J Am Acad Dermatol; 2024 May; 90(5):1059-1061. PubMed ID: 38246562
[No Abstract] [Full Text] [Related]
7. When to expect scalp hair regrowth during treatment of severe alopecia areata with baricitinib: insights from trajectories analyses of patients enrolled in two phase III trials.
King B; Shapiro J; Ohyama M; Egeberg A; Piraccini BM; Craiglow B; Sinclair R; Chen YF; Wu WS; Ding Y; Somani N; Dutronc Y
Br J Dermatol; 2023 Nov; 189(6):666-673. PubMed ID: 37708254
[TBL] [Abstract][Full Text] [Related]
8. Case report: Sequential therapy with dupilumab and baricitinib for severe alopecia areata with atopic dermatitis in children.
Fang H; Zhang F; Lin W; Jiang Y; Liu Q; Yang D
Front Immunol; 2024; 15():1395288. PubMed ID: 38903518
[TBL] [Abstract][Full Text] [Related]
9. Baricitinib improved alopecia areata concomitant with atopic dermatitis: A case report.
Uchida H; Kamata M; Nagata M; Fukaya S; Hayashi K; Fukuyasu A; Tanaka T; Ishikawa T; Ohnishi T; Tada Y
J Dermatol; 2021 Sep; 48(9):e472-e473. PubMed ID: 34151450
[No Abstract] [Full Text] [Related]
10. Alopecia areata treatment with baricitinib: different relapse phenotypes.
Dall'Oglio F; Nasca MR; Lacarrubba F; Vitale P; Micali G
J Dermatolog Treat; 2024 Dec; 35(1):2324832. PubMed ID: 38465657
[No Abstract] [Full Text] [Related]
11. Baricitinib: A Review in Severe Alopecia Areata.
Fung S; Shirley M
Am J Clin Dermatol; 2023 Jul; 24(4):661-668. PubMed ID: 37326792
[TBL] [Abstract][Full Text] [Related]
12. Complete response of extensive alopecia areata refractory to baricitinib after five months of treatment with upadacitinib.
De la Torre-Gomar FJ; Velasco-Amador JP; Prados-Carmona Á; Ruiz-Villaverde R
J Dermatolog Treat; 2024 Dec; 35(1):2304630. PubMed ID: 38240097
[No Abstract] [Full Text] [Related]
13. Atopic dermatitis and multilocular alopecia areata simultaneously treated with baricitinib.
Pestana M; Brito Caldeira M; Duarte B
Actas Dermosifiliogr; 2024 Feb; 115(2):T200-T201. PubMed ID: 37952837
[No Abstract] [Full Text] [Related]
14. Atopic Dermatitis and Multilocular Alopecia Areata Simultaneously Treated With Baricitinib.
Pestana M; Brito Caldeira M; Duarte B
Actas Dermosifiliogr; 2024 Feb; 115(2):200-201. PubMed ID: 36842474
[No Abstract] [Full Text] [Related]
15. Baricitinib as the first systemic treatment for severe alopecia areata.
Kincaid CM; Arnold JD; Mesinkovska NA
Expert Rev Clin Immunol; 2023 Jun; 19(6):565-573. PubMed ID: 37042112
[TBL] [Abstract][Full Text] [Related]
16. Long-term efficacy and safety of baricitinib in patients with severe alopecia areata: 104-week results from BRAVE-AA1 and BRAVE-AA2.
Senna M; Mostaghimi A; Ohyama M; Sinclair R; Dutronc Y; Wu WS; Yu G; Chiasserini C; Somani N; Holzwarth K; King B
J Eur Acad Dermatol Venereol; 2024 Mar; 38(3):583-593. PubMed ID: 38391212
[TBL] [Abstract][Full Text] [Related]
17. Baricitinib Therapy for Moderate to Severe Alopecia Areata: A Retrospective Review of 95 Japanese Patients.
Numata T; Irisawa R; Mori M; Uchiyama M; Harada K
Acta Derm Venereol; 2024 Jan; 104():adv18348. PubMed ID: 38248913
[No Abstract] [Full Text] [Related]
18. Treatment of alopecia areata of the beard with baricitinib.
Moussa A; Eisman S; Sinclair RD; Bhoyrul B
J Am Acad Dermatol; 2023 Apr; 88(4):948-950. PubMed ID: 36427662
[No Abstract] [Full Text] [Related]
19. Effectiveness and safety of baricitinib in patients with moderate-to-severe refractory alopecia areata in real world: An open-label, single-center study.
Bi L; Wang C; Du Y; Su T; Zhao M; Lin X; Fan W; Sun W
J Cosmet Dermatol; 2024 Apr; 23(4):1417-1421. PubMed ID: 38116864
[TBL] [Abstract][Full Text] [Related]
20. Efficacy and safety of the oral Janus kinase inhibitor baricitinib in the treatment of adults with alopecia areata: Phase 2 results from a randomized controlled study.
King B; Ko J; Forman S; Ohyama M; Mesinkovska N; Yu G; McCollam J; Gamalo M; Janes J; Edson-Heredia E; Holzwarth K; Dutronc Y
J Am Acad Dermatol; 2021 Oct; 85(4):847-853. PubMed ID: 34090959
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
